The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome

. 2014 ; 9 (12) : e114514. [epub] 20141208

Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25485546

UNLABELLED: DiGeorge syndrome (DGS) presents with a wide spectrum of thymic pathologies. Nationwide neonatal screening programs of lymphocyte production using T-cell recombination excision circles (TREC) have repeatedly identified patients with DGS. We tested what proportion of DGS patients could be identified at birth by combined TREC and kappa-deleting element recombination circle (KREC) screening. Furthermore, we followed TREC/KREC levels in peripheral blood (PB) to monitor postnatal changes in lymphocyte production. METHODS: TREC/KREC copies were assessed by quantitative PCR (qPCR) and were related to the albumin control gene in dry blood spots (DBSs) from control (n = 56), severe immunodeficiency syndrome (SCID, n = 10) and DGS (n = 13) newborns. PB was evaluated in DGS children (n = 32), in diagnostic samples from SCID babies (n = 5) and in 91 controls. RESULTS: All but one DGS patient had TREC levels in the normal range at birth, albeit quantitative TREC values were significantly lower in the DGS cohort. One patient had slightly reduced KREC at birth. Postnatal DGS samples revealed reduced TREC numbers in 5 of 32 (16%) patients, whereas KREC copy numbers were similar to controls. Both TREC and KREC levels showed a more pronounced decrease with age in DGS patients than in controls (p < 0.0001 for both in a linear model). DGS patients had higher percentages of NK cells at the expense of T cells (p < 0.0001). The patients with reduced TREC levels had repeated infections in infancy and developed allergy and/or autoimmunity, but they were not strikingly different from other patients. In 12 DGS patients with paired DBS and blood samples, the TREC/KREC levels were mostly stable or increased and showed similar kinetics in respective patients. CONCLUSIONS: The combined TREC/KREC approach with correction via control gene identified 1 of 13 (8%) of DiGeorge syndrome patients at birth in our cohort. The majority of patients had TREC/KREC levels in the normal range.

Zobrazit více v PubMed

Davies EG (2013) Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia. Front Immunol 4:322. PubMed PMC

Chinn IK, Milner JD, Scheinberg P, Douek DC, Markert ML (2013) Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomaly. Clin Exp Immunol 173:140–9. PubMed PMC

Gennery AR (2012) Immunological aspects of 22q11.2 deletion syndrome. Cell Mol life Sci 69:12–27. PubMed PMC

Murray JM, Kaufmann GR, Hodgkin PD, Lewin SR, Kelleher AD, et al. (2003) Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol Cell Biol 81:487–95. PubMed

Van Zelm MC, van der Burg M, Langerak AW, van Dongen JJM (2011) PID comes full circle: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol 2:12. PubMed PMC

Kwan A, Church JA, Cowan MJ, Agarwal R, Kapoor N, et al. (2013) Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol 132:140–50. PubMed PMC

Kelly BT, Tam JS, Verbsky JW, Routes JM (2013) Screening for severe combined immunodeficiency in neonates. Clin Epidemiol 5:363–9. PubMed PMC

Van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJM (2007) Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 204:645–55. PubMed PMC

Borte S, Wang N, Oskarsdóttir S, von Döbeln U, Hammarström L (2011) Newborn screening for primary immunodeficiencies: beyond SCID and XLA. Ann N Y Acad Sci 1246:118–30. PubMed

Patel K, Akhter J, Kobrynski L, Benjamin Gathmann MA, Davis O, et al. (2012) Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr 161:950–3. PubMed

Pongers-Willemse M, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, et al. (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 12:2006–14. PubMed

Weinberg K, Blazar BR, Wagner JE, Aqura E, Hill BJ, et al. (2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97:1458–1466. PubMed

Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, et al. (2013) Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles. J Allergy Clin Immunol 131:1437–40.e5. PubMed

Janda A, Sedlacek P, Mejstrikova E, Zdrahalova K, Hrusak O, et al. (2007) Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant 11:441–447. PubMed

Lima K, Abrahamsen TG, Foelling I, Natvig S, Ryder LP, et al. (2010) Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles. Clin Exp Immunol 161:98–107. PubMed PMC

Sottini A, Ghidini C, Zanotti C, Chiarini M, Caimi L, et al. (2010) Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin Immunol 136:217–27. PubMed

Lingman Framme J, Borte S, von Döbeln U, Hammarström L, Oskarsdóttir S (2014) Retrospective Analysis of TREC Based Newborn Screening Results and Clinical Phenotypes in Infants with the 22q11 Deletion Syndrome. J Clin Immunol. doi:10.1007/s10875-014-0002-y PubMed DOI

Šedivá A, Bartůňková J, Zachová R, Poloučková A, Hrušák O, et al. (2005) Early development of immunity in diGeorge syndrome. Med Sci Monit 11:CR182–7. PubMed

Cancrini C, Romiti ML, Finocchi A, Di Cesare S, Ciaffi P, et al. (2005) Post-natal ontogenesis of the T-cell receptor CD4 and CD8 Vbeta repertoire and immune function in children with DiGeorge syndrome. J Clin Immunol 25:265–74. PubMed

Pierdominici M, Mazzetta F, Caprini E, Marziali M, Digilio MC, et al. (2003) Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Exp Immunol 132:323–31. PubMed PMC

Den Braber I, Mugwagwa T, Vrisekoop N, Westera L, Mögling R, et al. (2012) Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 36:288–97. PubMed

Adams SP, Rashid S, Premachandra T, Harvey K, Ifederu A, et al. (2014) Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J Clin Immunol. 2014 Apr; 34(3):323–30. PubMed

McClory S, Hughes T, Freud AG, Briercheck EL, Martin C, et al. (2012) Evidence for a stepwise program of extrathymic T cell development within the human tonsil. J Clin Invest 122:1403–15. PubMed PMC

Junker K, Driscoll D (1995) Humoral immunity in DiGeorge syndrome. J Pediatr 127:231–7. PubMed

Fronkova E, Muzikova K, Mejstrikova E, Kovac M, Formankova R, et al. (2008)B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL. Bone Marrow Transplant 42(3):187–96. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...